Search results for “Coagulation Factor IX” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 231 patents, we discovered top 39 key players by total patent application. Novo Nordisk A/S, Chugai Pharmaceutical Co., Ltd., Bioverativ Therapeutics, Inc. are dominant in this area. They take 51.08% of the total patent filing.
Novo Nordisk A/S
Hovedstaden, Denmark
Patent: 49
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 45
Bioverativ Therapeutics, Inc.
Massachusetts, United States
Patent: 24
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 23
Octapharma AG
Schwyz, Switzerland
Patent: 13
Immuno AG
Austria
Patent: 11
Amunix Pharmaceuticals, Inc.
California, United States
Patent: 8
UCL Business Ltd.
United Kingdom
Patent: 7
Arecor Ltd.
Essex, United Kingdom
Patent: 6
Green Cross Corp.
South Korea
Patent: 4
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 75 patents applied in the last 5 years. We discover 18 most active companies in this area. The fast-growing Novo Nordisk A/S, Chugai Pharmaceutical Co., Ltd., Bioverativ Therapeutics, Inc. take 69.33% of patent filing during this period.
Novo Nordisk A/S
Hovedstaden, Denmark
Patent: 37
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 9
Bioverativ Therapeutics, Inc.
Massachusetts, United States
Patent: 6
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 5
Western University of Health Sciences
California, United States
Patent: 2
UCL Business Ltd.
United Kingdom
Patent: 2
Philips
Saudi Arabia
Patent: 2
Hualan Genetic Engineering Co Ltd
Henan Sheng, China
Patent: 1
Shanghai Taohua Biomedical Technology Partnership (Limited Partnership)
Shanghai Shi, China
Patent: 1
Hualan Biological Engineering Chongqing Co., Ltd.
Chongqing Shi, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 75 patents in last 5 years, we discover 12 new entrants. Western University of Health Sciences, Hualan Genetic Engineering Co Ltd, Shanghai Taohua Biomedical Technology Partnership (Limited Partnership) are the most active new entrants in this area.
Western University of Health Sciences
California, United States
Patent: 2
Hualan Genetic Engineering Co Ltd
Henan Sheng, China
Patent: 1
Shanghai Taohua Biomedical Technology Partnership (Limited Partnership)
Shanghai Shi, China
Patent: 1
Hualan Biological Engineering Chongqing Co., Ltd.
Chongqing Shi, China
Patent: 1
Hualan Biological Engineering, Inc.
Henan Sheng, China
Patent: 1
Jiangsu Gensciences lnc
Jiangsu Sheng, China
Patent: 1
West China Hospital of Sichuan University
China
Patent: 1
Shanghai Vitalgen BioPharma Co., Ltd.
China
Patent: 1
Suzhou Alphamab Co. Ltd.
Jiangsu Sheng, China
Patent: 1
Zhaoke Pharmaceutical (Hefei) Company Limited
Anhui Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 18 patents, we discovered top 7 universities and scientific research institutions by total patent application. University of Vermont, Western University of Health Sciences, Nara Medical University are dominant in this area. They take 38.89% of the total patent filing.
University of Vermont
Massachusetts, United States
Patent: 2
Western University of Health Sciences
California, United States
Patent: 2
Nara Medical University
Nara-ken, Japan
Patent: 2
University of Florida
United States
Patent: 1
Nihon University
Tokyo-to, Japan
Patent: 1
University of Science & Technology of China
Anhui Sheng, China
Patent: 1
Yangzhou University
Jiangsu Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: